[1. Murphy DJ, Striate GM. Mortality and morbidity associated with early-onset preeclampsia. Hypertens Pregnancy. 2000;19(2):221-31.10.1081/PRG-10010013810877990]Search in Google Scholar
[2. Noris M, Perico N, Remuzzi G. Mechanisms of disease: preeclampsia. Nat Clin Practe. 2005;1(2):98-114.10.1038/ncpneph003516932375]Search in Google Scholar
[3. Shennan AH, Redman C, Cooper C, Milne F. Are most maternal deaths from preeclampsia avoidable? Lancet 2012;379:1686-7.10.1016/S0140-6736(11)60785-X]Search in Google Scholar
[4. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592-94.10.1126/science.111172615947178]Search in Google Scholar
[5. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: The role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123(24):2856-69.10.1161/CIRCULATIONAHA.109.853127314878121690502]Search in Google Scholar
[6. Liu A, Wen SW, Bottomley J, Walker MC, Smith G. Utilization of health care services of pregnant women complicated by preeclampsia in Ontario. Hypertens Pregnancy. 2009;28(1):76-84.10.1080/1064195080236625219165672]Search in Google Scholar
[7. Delahaije DH, Smits LJ, van Kuijk SM, Peeters LL, Duvekot JJ, Ganzevoort W, et al. Care-as- usual provided to formerly preeclamptic women in the Netherlands in the next pregnancy: health care consumption, costs and maternal and child outcome. Eur J Obstet Gynecol Reprod Biol 2014;179:240-5.10.1016/j.ejogrb.2014.04.03324835859]Search in Google Scholar
[8. Rath W, Fischer Th. The Diagnosis and Treatment of Hypertensive Disorders of Pregnancy. New Findings for Antenatal and Inpatient Care. Dtsch Arztebl Int 2009;106(45): 733-8.10.3238/arztebl.2009.0733]Search in Google Scholar
[9. Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, et al. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J ObstetGynecol2010;202(2):161.e1–161.e11.10.1016/j.ajog.2009.09.01619850276]Search in Google Scholar
[10. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Zeisler H, Calda P, et al. New gestational phase specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension 2014;63(2):346-52.10.1161/HYPERTENSIONAHA.113.0178724166751]Search in Google Scholar
[11. Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstr M, et al. Predictive value of the sFlt-1: PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374(1):13-22.10.1056/NEJMoa141483826735990]Search in Google Scholar